Cell Biotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	17,139	4,757	7,884	8,458	9,860
Short-Term Investments	75,923	74,450	56,515	37,671	18,675
Trading Asset Securities	-	8,247	5,933	19,239	29,299
Cash & Short-Term Investments	93,062	87,454	70,332	65,368	57,834
Cash Growth	6.41%	24.34%	7.59%	13.03%	5.37%
Accounts Receivable	4,357	3,991	4,595	4,566	4,664
Other Receivables	736.95	682.88	943.86	583.11	268.43
Receivables	5,362	4,976	5,740	5,330	5,216
Inventory	4,616	4,203	4,122	4,102	3,589
Prepaid Expenses	459.01	287.27	691.85	500.5	292.5
Other Current Assets	214.29	228.19	1,044	354.58	587.81
Total Current Assets	103,712	97,148	81,929	75,655	67,519
Property, Plant & Equipment	30,460	30,463	32,937	33,638	34,057
Long-Term Investments	501.94	501.94	501.94	3,786	8,427
Other Intangible Assets	1,176	1,606	1,599	1,793	1,536
Long-Term Accounts Receivable	0	0	0	0	0
Long-Term Deferred Tax Assets	270.14	216.96	182.29	449.3	751.56
Other Long-Term Assets	452.94	461.66	491.37	517.21	585.15
Total Assets	136,572	130,398	117,641	115,839	112,877
Accounts Payable	458.36	680.27	578.39	1,370	1,224
Accrued Expenses	395.45	481.51	489.15	443.91	470.95
Current Portion of Leases	350.13	650.28	621.14	600.78	402.89
Current Income Taxes Payable	187.23	1,404	-	1,038	814.73
Current Unearned Revenue	33.27	27.57	27.03	30.9	50.44
Other Current Liabilities	3,436	2,619	3,106	3,905	2,802
Total Current Liabilities	4,861	5,863	4,821	7,389	5,766
Long-Term Leases	75.25	366.66	934.17	357.79	423.49
Other Long-Term Liabilities	0	-	-	-	0
Total Liabilities	4,936	6,229	5,755	7,747	6,189
Common Stock	4,700	4,700	4,700	4,700	4,700
Additional Paid-In Capital	12,760	12,760	12,760	12,760	12,760
Retained Earnings	137,309	130,264	118,217	114,993	109,894
Treasury Stock	-23,978	-23,978	-23,978	-23,978	-20,258
Comprehensive Income & Other	845.33	422.69	186.4	-382.91	-408.42
Shareholders' Equity	131,637	124,168	111,885	108,092	106,687
Total Liabilities & Equity	136,572	130,398	117,641	115,839	112,877
Total Debt	425.38	1,017	1,555	958.57	826.38
Net Cash (Debt)	92,636	86,437	68,777	64,409	57,007
Net Cash Growth	7.17%	25.68%	6.78%	12.98%	6.47%
Net Cash Per Share	13531.52	12628.32	10049.37	9342.06	8061.43
Filing Date Shares Outstanding	6.85	6.84	6.84	6.84	7.07
Total Common Shares Outstanding	6.85	6.84	6.84	6.84	7.07
Working Capital	98,852	91,286	77,108	68,266	61,754
Book Value Per Share	19210.93	18142.94	16348.17	15793.91	15086.68
Tangible Book Value	130,461	122,563	110,286	106,299	105,151
Tangible Book Value Per Share	19039.36	17908.31	16114.53	15531.88	14869.49
Land	9,696	9,696	9,765	9,765	9,765
Buildings	22,296	19,675	19,537	13,349	13,854
Machinery	26,322	25,847	25,644	7,228	8,033
Construction In Progress	117.7	385.42	338.95	993.9	247.26

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.